ELIZABETH MENTZER: Open Payments
NPI 1578889663 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,077 in 156 payments from 35 companies in 2025. Trend: 2023 $2,358 · 2024 $2,020 · 2025 $3,077
Food & beverage: $3,000Education: $77
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $507 |
| AstraZeneca Pharmaceuticals LP | 13 | $392 |
| Amgen Inc. | 22 | $244 |
| ABBVIE INC. | 19 | $241 |
| Axsome Therapeutics, Inc. | 15 | $225 |
| Vanda Pharmaceuticals Inc. | 8 | $221 |
| Paratek Pharmaceuticals, Inc. | 5 | $178 |
| Novo Nordisk Inc | 4 | $83 |
| GENZYME CORPORATION | 4 | $83 |
| GlaxoSmithKline, LLC. | 1 | $80 |
Products named: REXULTI, FANAPT, TEZSPIRE, AIRSUPRA, Auvelity, DUPIXENT, NUZYRA, VRAYLAR.
Industry payments across KY — which companies pay providers there.
